chrX-136648254-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_ModerateBP6_ModerateBP7BS1BS2
The NM_000074.3(CD40LG):c.6C>T(p.Ile2=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000442 in 1,200,358 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 34 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.000027 ( 0 hom., 3 hem., cov: 22)
Exomes 𝑓: 0.000046 ( 0 hom. 31 hem. )
Consequence
CD40LG
NM_000074.3 synonymous
NM_000074.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0180
Genes affected
CD40LG (HGNC:11935): (CD40 ligand) The protein encoded by this gene is expressed on the surface of T cells. It regulates B cell function by engaging CD40 on the B cell surface. A defect in this gene results in an inability to undergo immunoglobulin class switch and is associated with hyper-IgM syndrome. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant X-136648254-C-T is Benign according to our data. Variant chrX-136648254-C-T is described in ClinVar as [Benign]. Clinvar id is 760534.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.018 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. gnomad4_exome allele frequency = 0.0000459 (50/1089660) while in subpopulation SAS AF= 0.000853 (46/53918). AF 95% confidence interval is 0.000656. There are 0 homozygotes in gnomad4_exome. There are 31 alleles in male gnomad4_exome subpopulation. Median coverage is 28. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 3 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD40LG | NM_000074.3 | c.6C>T | p.Ile2= | synonymous_variant | 1/5 | ENST00000370629.7 | NP_000065.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD40LG | ENST00000370629.7 | c.6C>T | p.Ile2= | synonymous_variant | 1/5 | 1 | NM_000074.3 | ENSP00000359663 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000271 AC: 3AN: 110698Hom.: 0 Cov.: 22 AF XY: 0.0000912 AC XY: 3AN XY: 32898
GnomAD3 genomes
AF:
AC:
3
AN:
110698
Hom.:
Cov.:
22
AF XY:
AC XY:
3
AN XY:
32898
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000982 AC: 18AN: 183289Hom.: 0 AF XY: 0.000207 AC XY: 14AN XY: 67771
GnomAD3 exomes
AF:
AC:
18
AN:
183289
Hom.:
AF XY:
AC XY:
14
AN XY:
67771
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000459 AC: 50AN: 1089660Hom.: 0 Cov.: 28 AF XY: 0.0000872 AC XY: 31AN XY: 355682
GnomAD4 exome
AF:
AC:
50
AN:
1089660
Hom.:
Cov.:
28
AF XY:
AC XY:
31
AN XY:
355682
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000271 AC: 3AN: 110698Hom.: 0 Cov.: 22 AF XY: 0.0000912 AC XY: 3AN XY: 32898
GnomAD4 genome
AF:
AC:
3
AN:
110698
Hom.:
Cov.:
22
AF XY:
AC XY:
3
AN XY:
32898
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Hyper-IgM syndrome type 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 14, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at